Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Summary Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2020-09, Vol.123 (5), p.694-697
Main Authors: Saini, Kamal S., Lanza, Carlo, Romano, Marco, de Azambuja, Evandro, Cortes, Javier, de las Heras, Begoña, de Castro, Javier, Lamba Saini, Monika, Loibl, Sibylle, Curigliano, Giuseppe, Twelves, Chris, Leone, Manuela, Patnaik, Mrinal M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19.
ISSN:0007-0920
1532-1827
DOI:10.1038/s41416-020-0948-x